BioLine RX Ltd (NASDAQ:BLRX)
| 2.60 Delayed Data As of Dec 09 |  +0.29 / +12.55%Today’s Change | 1.55 Today|||52-Week Range 13.05 | -60.36% Year-to-Date |
Latest BLRX News | Press Releases
No recent news for BioLine RX Ltd.
Today’s Trading
| Previous close | 2.31 |
| Today’s open | 2.38 |
| Day’s range | 2.34 - 2.70 |
| Volume | 316,111 |
| Average volume (3 months) | 91,812 |
| Market cap | $25.1M |
Data as of 4:00pm ET, 12/09/2019
Growth & Valuation
| Earnings growth (last year) | +22.49% |
| Earnings growth (this year) | +26.41% |
| Earnings growth (next 5 years) | -25.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZSANZosano Pharma Corp | -0.05 | -3.05% |
| FCSCFibrocell Science In... | +0.01 | +0.33% |
| KZIAKazia Therapeutics L... | +0.11 | +2.53% |
| VVUSVivus Inc | +0.02 | +0.72% |
Data as of 4:00pm ET, 12/09/2019
Financials
| Next reporting date | March 18, 2020 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$22.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Modi'in, Tel Aviv |
Forecasts
